Inmed Pharmaceuticals Inc. buy Bankster
Start price
21.01.25
/
50%
€6.45
Target price
21.01.26
-
Performance (%)
-54.42%
End price
31.01.25
€2.94
Summary
This prediction ended on 31.01.25 with a price of €2.94. The BUY prediction by Bankster for Inmed Pharmaceuticals Inc. performed very badly with a performance of -54.42%. Bankster has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Inmed Pharmaceuticals Inc. | - | - | - |
| iShares Core DAX® | 0,79 % | 1,97 % | 13,39 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % | 39,72 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % | 49,89 % |
| iShares S&P 500 | 2,50 % | 2,76 % | 30,23 % |
According to Bankster what are the pros and cons of Inmed Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Bankster for this prediction
In the thread Inmed Pharmaceuticals Inc. diskutieren
Buy Inmed Pharmaceuticals Inc.